Dysfunction of complex I (CI) of the mitochondrial electron transport chain (ETC) features prominently in human pathology. Cell models of ETC dysfunction display adaptive survival responses that still are poorly understood but of relevance for therapy development. Here we comprehensively examined how primary human skin fibroblasts adapt to chronic CI inhibition. CI inhibition triggered transient and sustained changes in metabolism, redox homeostasis and mitochondrial (ultra)structure but no cell senescence/death. CI-inhibited cells consumed no oxygen and displayed minor mitochondrial depolarization, reverse-mode action of complex V, a slower proliferation rate and futile mitochondrial biogenesis. Adaptation was neither prevented by antioxidants nor associated with increased PGC1-α/SIRT1/mTOR levels. Survival of CI-inhibited cells was strictly glucose-dependent and accompanied by increased AMPK-α phosphorylation, which occurred without changes in ATP or cytosolic calcium levels. Conversely, cells devoid of AMPK-α died upon CI inhibition. Chronic CI inhibition did not increase mitochondrial superoxide levels or cellular lipid peroxidation and was paralleled by a specific increase in SOD2/GR, whereas SOD1/CAT/Gpx1/Gpx2/Gpx5 levels remained unchanged. Upon hormone stimulation, fully adapted cells displayed aberrant cytosolic and ER calcium handling due to hampered ATP fueling of ER calcium pumps. It is concluded that CI dysfunction triggers an adaptive program that depends on extracellular glucose and AMPK-α. This response avoids cell death by suppressing energy crisis, oxidative stress induction and substantial mitochondrial depolarization.
Introduction
Mitochondria are functionally and morphologically heterogeneous organelles that are crucially involved in cell metabolism and the sensing and regulation of calcium signaling [1] . Mitochondrial dysfunction is associated with a range of human pathologies that often arise as a consequence of oxidative phosphorylation (OXPHOS) system defects [2, 3] . The OXPHOS system consists of four electron transport chain (ETC) complexes (CI-CIV) and the ATP-generating F o F 1 -ATP synthase (CV). OXPHOS complexes are embedded in the mitochondrial inner membrane (MIM), which surrounds the mitochondrial matrix compartment and is itself enveloped by an outer membrane (MOM). Functionally, protons (H + ) are transported out of mitochondrial matrix across the MIM by the integrated action of the ETC complexes. This generates an inward-directed proton-motive force (PMF), consisting of a proton (ΔpH) and electrical gradient (Δψ). These gradients sustain ATP production [4] and other mitochondrial functions, and (co)prevent the release of pro-apoptotic factors [5] . At the cellular level, OXPHOS dysfunction triggers adaptive programs that may prevent detrimental cellular consequences and cell death [6] [7] [8] . These programs feature alterations in redox state and antioxidant responses, mitophagy induction, glycolysis upregulation, changes in mitochondrial morphology and induction of mitochondrial biogenesis [9] . Adaptation is performed by a complex network of proteins including AMP-activated protein kinase (AMPK), peroxisome proliferator-activated receptor γ coactivator α (PGC-1α), silent mating type information regulation 2 homolog 1 (SIRT1), superoxide dismutases (SODs), mechanistic target of rapamycin (mTOR) and mitochondrial fission and fusion factors [10, 11] . Although it has been proposed that exogenous stimulation of this adaptive network is of therapeutic value [2, 3, 12, 13] , our understanding of this program at the cellular level is still limited. Mitochondrial complex I (CI or NADH:ubiquinone oxidoreductase; EC 1.6.5.3), links NADH oxidation to ubiquinone reduction to drive H + transport. CI deficiency is the most common cause of OXPHOS disease in children. Patients with CI deficiency frequently suffer from Leigh or Leigh-like syndrome (OMIM 256000), a severe neurodegenerative disorder for which currently no cure is available [14, 15] . The pathophysiology of CI deficiency has been studied in patient-and animal-derived cell models [2, [14] [15] [16] [17] [18] [19] . Cell models display various physicochemical aberrations including reduced CI activity, partial Δψ depolarization, increased mitochondrial NADH levels, elevated reactive oxygen species (ROS) levels and aberrant calcium (Ca 2 + ) and ATP homeostasis [20] . Importantly, not all cell parameters (e.g. mitochondrial morphology, ROS levels) are consistently altered in the different cell model systems [15, 19, 21, 22] . These discrepancies likely arise from the use of different cell types, culture conditions and genetic variability [2, 6, 9, 15, 19] . As an alternative strategy, cellular adaptation to CI dysfunction can also be studied using chemical inhibitors [8, 23, 24] . This approach circumvents potential problems associated with inter-patient genetic variability and allows side-by-side comparison of healthy and OXPHOS-deficient cells under controlled conditions. Here we applied the plant alkaloid rotenone (ROT), which binds at the CI ubiquinone binding site, thereby inhibiting ubiquinone reduction and CI activity, to gain comprehensive insights into the adaptive program. Undertaking this approach was triggered by the difficulty of establishing "ideal" controls for studies using patient-derived cell lines. The latter likely results from individual metabolismrelated genetic variation. Moreover, patient-derived cell lines represent a "final stage" of metabolic adaptation to mitochondrial dysfunction. This precludes the analysis of the adaptive process in time. We establish that chronic CI dysfunction induces transient and sustained cell responses but not cell senescence or death. In particular, glucose supply and the AMPK α-subunit were proven to be crucial for cell survival during CI dysfunction.
Materials and Methods

Cell culture
Fibroblasts (CT5120) were obtained from a healthy individual according to the relevant Institutional Review Boards. Culturing of fibroblasts and HEK 293 cells is described in the Supplement. Immortalized primary AMPKα1 -/-
AMPKα2
-/-(AMPKα-null) and genetically matched WT mouse embryonic fibroblasts (MEFs) were cultured as described previously [25] .
Enzyme activities, live-cell oxygen consumption and lactate/pyruvate measurements
Activity of mitochondrial enzymes, cellular oxygen consumption and lactate/pyruvate levels in the culture medium were determined as described in the Supplement.
Fluorescence and bioluminescence analysis of Ca
2+ and/or ATP levels
] was quantified using the ratiometric Ca 2+ indicator fura-2 as described previously [26] . The D1ER Ca 2+ sensor protein was used to monitor ER [Ca
2+
] as described in the Supplement. Free cytosolic [ATP] was quantified using the ATP-sensing protein ATeam 1.03 as described previously [19, 21] . Free mitochondrial [ATP] was measured using a mitochondria-targeted luciferase (mitLUC; [27] ). Details are provided in the Supplement.
Mitochondrial TMRM fluorescence, mitochondrial morphology and NAD(P)H autofluorescence
Mitochondrial tetramethyl rhodamine methyl ester (TMRM; Invitrogen) staining was used to estimate mitochondrial membrane potential, quantify mitochondrial morphology, and analyze mitochondrial movement as described previously [28] . TMRM operated in "non-quenching" mode. Measurement of mitochondrial NAD(P)H autofluorescence was carried as described previously [29] .
ROS levels and cellular lipid peroxidation
ROS levels and lipid peroxidation were quantified by measuring the oxidation of hydroethidium (HEt), a mitochondria-targeted HEt variant (MitoSOX Red), CM-H 2 DCF (5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein) and C11 BODIPY 581/591 (C11), as described in the Supplement.
Electron microscopy (EM), tubulin staining and Western blot analysis
EM was performed as described previously [30] . Tubulin staining, Western blotting and antibodies are described in the Supplement.
Image and data analysis
Images were processed and analyzed using Image Pro Plus 6.3 software (Media Cybernetics, Silver Spring, MD, USA). Visualization of numerical results, curve fitting and statistical analysis was performed using Origin Pro 7.5 (OriginLab Corp., Northampton, MA, USA). Unless stated otherwise, average data is presented as the mean ± SE (standard error). Statistical differences were determined using either a twopopulation or one-population Student's t-test (Bonferroni corrected).
Results
A cell model to study adaptive responses in CI dysfunction
Primary human skin fibroblasts were cultured in the presence of the specific CI inhibitor ROT and used to study adaptive changes. Importantly, we used the lowest [ROT] that maximally inhibited CI activity (100 nM; [9, 23, 30, 31] ) and analyzed its effects after 72 h and 5 wks. Special care was taken to prevent artifacts of fibroblast aging during cell culture and no signs of cell senescence or apoptosis induction were observed (see Supplement). Within the first 2 wks of ROT-treatment twice the number of cells had to be seeded to reach confluence within a week. Since cell death was not observed, this indicates that ROT-treated cells proliferate~2-fold slower than vehicle-treated (CT) cells. Cell proliferation remained stable at this reduced rate for the remainder of time. After 5 wks, ROT was removed from the medium and cell proliferation normalized again within 3 wks. The latter cells are referred to as "released cells" in the remainder of this study.
CI inhibition blocks cellular O 2 consumption, partially depolarizes Δψ and triggers CV reverse-mode action
Routine cellular O 2 consumption was fully inhibited (i.e. identical to minimal respiration) and FCCP-induced uncoupling failed to stimulate O 2 consumption rate in ROT-treated cells (Fig. 1A) . This demonstrates that the ETC is fully inhibited and suggests that ROT-insensitive pathways of ETC electron input are absent. Mitochondrial TMRM fluorescence was reduced by 12% in ROT-treated cells (Fig. 1B) . When the cells were treated with the specific CIII-inhibitor antimycin A in the absence of ROT, mitochondrial TMRM fluorescence dropped much further [9] . Therefore we conclude that Δψ is partially depolarized in ROT-treated cells. In released cells no Δψ depolarization was observed (Fig. S1B) . This is compatible with previous results indicating that, in the absence of ETC activity, Δψ can be largely maintained by reversemode action of CV fueled by glycolytic ATP [32] . Detected free ATP levels in the cytosol ([ATP] c ; Fig. 1C ) and mitochondrial matrix ([ATP] c ; Fig. 1D ) were similar for CT and ROT-treated cells. Relative to CT, total cellular ATP levels were 2-fold increased in 5 wks ROT-treated fibroblasts (Fig. S2E) . However the latter cells were 2-fold larger than CT cells (see below) and therefore the total ATP level is not altered. In CT cells replacement of extracellular glucose (GLC; 5 mM) by the glycolysis inhibitor 2-Deoxy-D-glucose (2-DG; 5 mM) induced a biphasic decay in [ATP] c ( Fig. 1E ; arrow continuous line; a, b). When the above maneuver was performed in the presence of OLI (10 μM, 30 min pre-treatment), phase-a decay (a') was not affected whereas phase-b decay (b') was 3-fold slower ( Fig. 1E; dotted line; Fig. 1H ). These results suggest that, during phase-a, sufficient ETC substrates are present to maintain Δψ and that phase-b starts when these intermediates are depleted and CV reverse-mode action is triggered. The latter is compatible with the fact that ROT-treated cells displayed a monophasic [ATP] c decrease ( Fig. 1F-G ; continuous lines; c, f). This decrease was up to 3-fold faster than in CT cells (Fig. 1H) , demonstrating that maintaining [ATP] c is more sensitive to glycolysis inhibition in ROT-treated fibroblasts than in CT cells. In ROT-treated cells OLI slowed down the 2-DG-induced [ATP] c decay up to 5-fold ( Fig. 1F-G ; dotted lines; d, e and g, h). The [ATP] c curves did not overlap for the ROT and ROT + OLI conditions, compatible with CV already running in reverse-mode prior to 2-DG application. In contrast to CT cells, ROT-treated cells died within 24 h when transferred from the standard GLC-containing culture medium to a GLC-free galactose(GAL)/glutamine(GLN)-containing medium (3 independent experiments). These results demonstrate that CI inhibition induces a strictly glucose-dependent phenotype. Taken together, the above findings demonstrate that [ATP] c , [ATP] m and total ATP are maintained at normal levels by glycolysis in ROT-treated cells and that ATP is consumed by CV reverse-mode action to largely preserve Δψ.
3.3. CI inhibition increases extracellular lactate/pyruvate ratio, alters redox homeostasis and increases SOD2 and glutathione reductase levels CT cells released both lactate (L) and pyruvate (P) in the culture medium and ROT-treatment progressively increased the L/P ratio ( Fig. 2A) . A similar increase was observed in mitochondrial NAD(P)H autofluorescence ( Fig. 2B) , compatible with reduced CI-mediated NADH oxidation to NAD + [33] and/or increased glycolytic NADH production. Oxidation of the ROS-reporter molecule CM-H 2 DCF was similar in CT and ROT-treated cells (Fig. 2C) . When excited at 490 nm, oxidation of hydroethidium (HEt) and its mitochondriatargeted variant MitoSOX Red was increased after 72 h ROT treatment and, to a lesser extent, after 5 wks (Fig. 2D) . In released cells the NAD(P)H level and HEt oxidation normalized again (Fig. S1A ).
The ROT-induced increase in MitoSOX Red signal was less than for HEt, suggesting that HEt oxidation is less specific for mitochondriagenerated ROS. Using a more superoxide-specific excitation wavelength (405 nm) revealed that mitochondrial MitoSOX Red oxidation was significantly increased at 72 h but normal at 5 wks (Fig. 2D ). Cellular lipid peroxidation transiently increased after 72 h (Fig. 2E ).
Western blot analysis revealed increased levels of the mitochondrial manganese (Mn) superoxide dismutase (SOD2) and glutathione reductase (GR) in ROT-treated cells ( Fig. 2F -G). SOD2 plays an important role in protecting mitochondrial components from superoxide mediated damage. GR is an enzyme that catalyzes the reduction of glutathione disulfide (GSSG) to glutathione (GSH), which is a key cellular antioxidant [34] . These results suggest that CI inhibition increases mitochondrial superoxide levels and lipid peroxidation, which are opposed by the action of SOD2 and GR. To determine whether ROS are mediating adaptation to CI inhibition, ROTtreated cells were incubated with the antioxidants ascorbic acid (AscA), Trolox (Tx), N-acetylcysteine (NAC) or the MIM-targeted antioxidant MitoQ10 for 24 h. No effect on cell survival was observed ( Fig. S2D ), possibly suggesting that increased ROS levels are not essential mediators of adaptation.
CI inhibition increases cell size and transiently alters mitochondrial morphology
We previously observed that elevated lipid peroxidation levels were paralleled by increased mitochondrial length and degree of branching in 72 h ROT-treated cells [23] . Moreover, alterations in mitochondrial morphology appear to be linked to CI dysfunction and ROS levels [22, 26, 28, 35, 36] . Relative to CT, 5 wks ROT-treated cells were 2-fold larger ( Fig. 3A-F) , contained 2-fold more mitochondria ( Fig. 3B -G) and a 2-fold larger endoplasmic reticulum (ER; Fig. S1D ). Cellular hypertrophy was also previously observed in patient tissues [37] and paralleled by a proportional increase in levels of the MOM fission protein Dynamin-related protein 1 (Drp1; (Fig. 3H ) and more filamentous (Fig. 3J) . The latter was associated with increased mitochondrial matrix connectivity (Fig. S2G) . In released cells all mitochondrial morphology parameters were normal (Fig. S1B ). ROT treatment reduced mitochondrial motility (Fig. 3C ) but did not affect mitochondrial aspect ratio (Fig. 3I ) nor cellular tubulin network organization (Fig. 3D) . Although mitochondria possess a less condensed mitochondrial matrix in glycolytic cancer cells [38] , matrix decondensation and ultrastructural alterations were not observed in ROT-treated cells (Fig. 3E, S3 , S5 and S5). The latter is supported by matrix protein diffusion analysis in ROTtreated fibroblasts and cells from CI-deficient patients [30, 39] . Compatible with glycolysis induction (see above), glycogen granules were present in CT but virtually absent in ROT-treated cells (Fig. 3E, S3 , S5 and S5).
Adaptation to CI inhibition involves mitochondrial biogenesis and requires the AMPK-α subunit
Mitochondrial dysfunction is often paralleled by induction of mitochondrial biogenesis [40] . ROT-treated cells displayed increased activity of the mitochondrial matrix enzyme citrate synthase (CS), a commonly used surrogate marker of mitochondrial volume and content (Fig. S2F ). This was accompanied by elevated protein levels of OXPHOS subunits (Fig. 4A-B ) and increased activity of CII and CIV ( Fig. S2F ; measured in isolated mitochondria under V max conditions in the absence of ROT). The p66shc protein displays an inherent ROS-producing capacity, regulates organismal lifespan and shifts metabolism towards mitochondrial respiration [41] . Ser36-phosphorylation of p66shc (P-p66shc) is stimulated by ROS and increases in mitochondrial disease patients with neuropathy, ataxia and retinitis pigmentosa (NARP; [42] ). ROTtreated cells also showed increased levels of P-p66shc (Fig. 4A-G) . Although 5 wks ROT-treated cells displayed elevated levels of OXPHOS proteins, P-p66shc and CII/CIV enzymatic activity, this adaptation is likely futile since cell death and O 2 consumption were not increased under these conditions relative to 72 h ROT-treated cells. We also observed a substantial increase in the levels of the AMPK-α subunit (AMPK-α) and Thr172-phosphorylated AMPK (P-AMPK-α) in ROT treated cells (Fig. 4C-G) . AMPK is a central nutrient and energy sensor that regulates cellular energy homeostasis [43] . Expression of other important proteins involved in metabolic regulation was not affected by ROT treatment (PGC-1α, SIRT1; Fig. 4D -E-G) or not detectable (mTOR; Fig. 4F-G) . Importantly, in the above analysis protein levels and enzymatic activity were normalized on cellular actin levels and protein amount (mg), respectively. Therefore it is highly unlikely that the observed increases are only a consequence of the ROT-induced increase in cell size. Both the amount of P-AMPK-α and AMPK-α were increased to the same extent (i.e. both proteins showed a 4-to 5-fold increase in levels in Fig. 4G ). This suggests that although the ratio P-AMPK-α/ AMKP-α is not changed, the net levels of P-AMPK-α and AMKP-α are higher in ROT-treated cells. Given this observation, we next investigated the role of this protein in more detail using genetically matched wild type (WT) and AMPK-α1
-/-(AMPK-α-null) mouse embryonic fibroblasts (MEFs; [25] ). WT MEFs cultured in the presence of ROT (100 nM, 72 h) were able to proliferate, albeit more slowly, whereas AMPK-α-null MEFs did not survive (Fig. 5) . This demonstrates that AMPK-α is crucial for cell adaptation and survival during CI inhibition.
3.6. CI inhibition slows endoplasmic reticulum Ca 2+ reuptake after hormone stimulation
To determine how adapted cells coped with conditions of increased ATP demand, cells were stimulated with the hormone bradykinin (Bk; [27] ), which triggers Ca 2+ release from the endoplasmic reticulum (ER) and stimulates ATP-consuming Ca 2+ -ATPases at the plasma membrane (PMCAs) and the sarco/endoplasmic reticulum (SERCAs). In CT fibroblasts, Ca 2+ enters the mitochondrial matrix and increases ETC-mediated ATP production, which is primarily used for SERCA fueling [44, 45] . In 5 wks ROT-treated cells ER Ca 2+ uptake (Fig. 6A-B) and rate of cytosolic Ca 2+ removal (Fig. 6C-D Fig. S1E ), the rate of ER Ca 2+ release (Fig. S1F) , the extent of ER refilling after Bk stimulation (Fig. S1E) , the resting cytosolic ] c signal (Fig. S1H) . These results suggest that glycolytic ATP generation suffices to sustain normal ER and cytosolic Ca 2+ levels under resting conditions in ROT-treated and fully adapted cells. However, this adaptation does not allow for proper ATP fueling of SERCAs upon cell stimulation.
Discussion
In this study we aimed to gain comprehensive insights into the adaptive program triggered by mitochondrial CI dysfunction in primary human skin fibroblasts (Fig. 7) . To circumvent potential problems associated with patient-derived CI-deficient cells (see Introduction) and allow time-dependent analysis we here chose to use a chemical inhibitor (ROT) to induce CI dysfunction. It is demonstrated that chronic CI inhibition is reversible, fully blocks ETC function and induces a nonsenescent phenotype that is characterized by a partially depolarized Δψ, CV reverse-mode action but normal resting ATP levels. Also other transient and sustained cell responses were observed and extracellular GLC and the AMPK α-subunit appeared to be crucial for cell survival ( Fig. 7) . Although fully adapted, hormone stimulation of CI-inhibited cells induced aberrant Ca 2+ signals. This suggests that ATP fueling of endoplasmic reticulum calcium pumps is hampered.
CI inhibition blocks ETC activity and induces partial Δψ depolarization and CV reverse-mode action but does not affect ATP levels
In ROT-treated cells, routine, leak, maximal and minimal cellular O 2 consumption were identical. This means that ETC-dependent O 2 consumption and ATP production are blocked in ROT-treated cells. These findings suggest that CII, which is part of both the ETC and TCA-cycle, is not actively contributing to O 2 consumption in ROTtreated cells. The latter might result from the increased NADH levels in the mitochondrial matrix, leading to inhibition of the TCA cycle. In contrast, HEK293 cells that were chronically treated with ROT still displayed CII-mediated residual O 2 consumption [21] . This difference likely relates to the observation that the cellular "context" (e.g. cell immortalization, external glucose concentration, culture conditions, cell type, cell metabolic state) appears to affect the cellular consequences of genetic and inhibitor-induced CI deficiency [46] . In the fully adapted state, Δψ was largely maintained by CV reverse-mode action in ROT-treated fibroblasts. This is important since Δψ is required for mitochondrial substrate/ion-exchange, protein import and mitochondrial fusion (see [9] and the references therein). In resting ROT-treated cells, no change in [ATP] c , [ATP] m and total-cell ATP levels was observed, demonstrating that the reduction in mitochondrial ATP production is fully compensated for.
CI inhibition induces a fully glycolytic phenotype
ROT-treated cells displayed a reduction in glycogen granules and an increased L/P ratio in the culture medium. This is compatible with stimulation of the glycolysis pathway. Such an increase was previously linked to the presence of a respiratory chain defect in cultured fibroblasts from patients with mitochondrial disorders [47] . Concerning lactate levels, the values obtained for CT cells in this study (~8 mM) closely matches those presented previously [48] . Although cells can take up pyruvate from the culture medium [49] , adherent human skin fibroblasts can also release pyruvate [50] . In our study the culture medium did not contain pyruvate. We observed that CT and 72 h ROT-treated fibroblasts released~0.2 mM of pyruvate into the medium during a period of 72 h, compatible with previous results [50] . The amount of pyruvate in the medium was 2-fold lower in cells treated for 5 wks with ROT (i.e.~0.10 mM), suggesting that less pyruvate is released and more pyruvate is metabolized by the cell at this time. CT cells survived in a GAL/GLN-containing medium without GLC. Although GLN was also present in the normal GLC-containing medium, cells preferentially consume GLC under these conditions [38, 51, 52] . GAL enters the glycolysis through the Leloir pathway and this occurs at a significantly lower rate than GLC entry in glycolysis. The residual levels of glycolytic intermediates produced by GAL metabolism are funneled into the pentose phosphate pathway [52] [53] [54] . Therefore, similar to certain cancer cells [38] , fibroblasts in GAL/GLN medium rely on GLN-driven mitochondrial ATP production [55] . GLN, essential for cell growth, is taken up by the cell and converted to glutamate (GLU) in the mitochondrial matrix. In cancer cells, GLN also provides a source of reduced nitrogen allowing nucleotide production and non-essential amino acids. Additionally, GLN plays a role in the uptake of essential amino acids, can maintain the TCA cycle when GLC levels are limiting and can support NADPH production. The latter is necessary for lipid and nucleotide biosynthesis and antioxidant recycling [9, 56] . In contrast to CT cells, ROT-treated cells cannot survive without GLU because glutaminolysis requires an active ETC for ATP production. It is unlikely that ATP is supplied by β-oxidation-mediated production of acetylCoenzyme A since this route also requires an active ETC. From the above, we conclude that ROT-treated human skin fibroblasts have switched to a fully glycolytic phenotype.
CI inhibition induces a transient increase in mitochondrial ROS levels and cellular lipid peroxidation
Impairment of mitochondrial function has been linked to increased ROS levels and oxidative stress induction, potentially playing a role in mitochondrial disease progression. The current study demonstrates that ROT-induced CI inhibition stimulates HEt and MitoSOX Red oxidation after 72 h of treatment. However, HEt and MitoSOX Red oxidation were significantly lower after 5 wks than after 72 h of ROT treatment. When a more specific detection method for quantification of mitochondrial superoxide levels was applied (i.e. measuring MitoSOX Red oxidation products at 405 nm excitation; [57, 58] ), no significant increase was detected after 5 wks of ROT treatment. Similarly, cellular lipid peroxidation was increased after 72 h ROT treatment and normal again after 5 wks. Superoxide is detoxified by the action of superoxide dismutases (SODs) present in the IMS/cytosol (SOD1 or CuZnSOD) and in the mitochondrial matrix/MIM (SOD2 or MnSOD). Compatible with the normalization of mitochondrial superoxide levels and absence of lipid peroxidation in 5 wks ROT-treated cells, ROT treatment specifically increased SOD2 levels but not SOD1 levels. These results suggest that CI inhibition increases mitochondrial superoxide levels and lipid peroxidation, which are opposed by adaptive upregulation of SOD2 and GR. In addition, SOD2 upregulation might be involved in preserving the proliferative capacity of human fibroblasts [59] .
CI inhibition transiently alters mitochondrial structure and matrix connectivity
72 h ROT treatment induced an increase in mitochondrial length, degree of branching and matrix connectivity, whereas 5 wks ROT treatment led to a 2-fold increase in the number of mitochondria per cell, without alterations in mitochondrial shape. We previously Fig. 7 . Cellular consequences of CI inhibition and proposed adaptive mechanism in primary human skin fibroblasts. Chronic inhibition (5 wks) of mitochondrial complex I (CI) by rotenone (ROT) induces cellular consequences that trigger an adaptive response programme. These two phenomena are associated with various alteration in bioenergetics, cell growth, redox metabolism, cell structure, mitochondrial (ultra)structure and calcium homeostasis. The adaptive response prevents cell death by limiting or preventing the detrimental effects of CI dysfunction. We here demonstrate that cells in which CI is chronically and completely inhibited strictly depend on extracellular glucose (GLC) for their survival. Also genetic ablation of AMPK-α was lethal in ROT-treated but not wild type mouse embryonic fibroblasts. We further demonstrate that various exogenously-added antioxidants were unable to prevent the survival of ROT-treated cells, suggesting that ROS do not play a key role in the adaptive response.
proposed [23] that increased mitochondrial connectivity might serve as a protective mechanism, for instance to share oxidative damage and antioxidants [35] . This idea is supported by the observation that cells display increased mitochondrial fusion leading to a closed network when subjected to modest levels of stress [60] . Moreover, mitochondrial networking protected β-cells from nutrient-induced apoptosis [61] .
CI inhibition induces cell hypertrophy but not cell senescence
ROT-treated fibroblasts ultimately displayed a 2-fold increase in cell size, paralleled by proportional increases in the number of mitochondria, ER size and total-cell ATP levels. In heart, hypertrophy can be physiological or pathological, depending on the nature of the stimulus (e.g. adaptation to training vs. hypertension), and is characterized by cardiomyocyte enlargement [62] . Cardiac hypertrophy, as well as mitochondrial (hyper) biogenesis ('ragged red fibers') in skeletal muscle biopsies, was also observed in children with inherited isolated CI deficiency [14] . In compensative cardiac hypertrophy it appears that cardiac mass and mitochondrial content/function increase in parallel, whereas during progression to heart failure decreased mitochondrial biogenesis and oxidative capacity are observed [62] . In contrast to senescence fibroblasts can also display quiescence, a reversible growth/proliferation arrest induced by mitogen (serum) withdrawal, contact inhibition or loss of adhesion [7] . In the current study, special care was taken to keep cell cultures sub-confluent to prevent contact inhibition-induced quiescence. Primary human fibroblasts display high metabolic rates when induced into quiescence via contact inhibition [63, 64] . Contact-inhibited cells displayed lower glucose consumption, reduced lactate secretion, and a smaller size. All of these features were not observed in ROT-treated cells, strongly suggesting that these cells are not quiescent.
CI inhibition activates AMPK
We observed a 5-fold increase in the levels of AMPK-α and Thr172-phosphorylation AMPK-α (P-AMPK) in CI-inhibited cells. Moreover, AMPK-α-null MEFs did not survive upon ROT-induced CI inhibition. AMPK activation (phosphorylation) serves to maintain cellular energy stores by initiating metabolic and genetic events that restore ATP levels by switching on ATP-generating catabolic pathways (e.g. glycolysis, OXPHOS, fatty acid oxidation and glucose uptake) while inhibiting others that consume ATP but are not acutely required for survival (e.g. triglyceride/protein synthesis, fatty acid synthesis, glycogen synthesis, cholesterol synthesis and cell proliferation) [11, [65] [66] [67] . AMPK-α phosphorylation is primarily mediated by serine-threonine liver kinase B1 (LKB1), which is stimulated by an increase in [ ] c transient. These results demonstrate that glycolysis-generated ATP suffices to maintain normal ERCa in resting CI-inhibited fibroblasts. However, when ATP demand is acutely increased by Bk application, Ca 2+ -stimulated ETCmediated ATP production cannot be activated in CI-inhibited cells.
Since this mitochondrial ATP is primarily used for SERCA fueling [44, 45] , CI-inhibited cells display aberrant [Ca 2+ ] c decay kinetics.
Conclusions
Our results in primary human skin fibroblast suggest a model in which CI inhibition fully blocks ETC activity and triggers an adaptive survival program (Fig. 7) . As previously reviewed [9] , the fibroblast ROT model displays several aberrations also induced by ROT treatment in other cell types (e.g. increased ROS levels), fibroblasts from patients with inherited CI deficiency (e.g. increased ROS, elevated NAD(P)H levels, aberrant Ca 2+ handling, partial Δψ depolarization) and primary CI-deficient mouse fibroblasts and myoblasts (e.g. increased ROS) [9, 23, 46] . Adaptation did not require upregulation of PGC1-α, SIRT1 or mTOR but involved increased expression of (phosphorylated) AMPK-α. The importance of the latter protein is supported by the fact that CI-inhibition in AMPK-α-null MEFs was lethal. Although the exact mechanism of AMPK activation in CI-inhibited cells is still unclear, "classical" activators (i.e. a reduction in ATP amount or increased [Ca 2+ ] c levels) were not observed. To suppress mitochondrial superoxide levels and cellular lipid peroxidation, chronic CI inhibition was paralleled by upregulation SOD2 and GR. Moreover, various antioxidants did not trigger cell death in CI-inhibited cells. This suggests that ROS-signaling is not essential to keep the adaptive program in an activated state. CIinhibited fibroblasts became hypertrophic, displayed (futile) mitochondrial biogenesis and fully depended on glycolysis for ATP production. This ATP was used to fuel reverse-mode action of CV to maintain Δψ, which allows mitochondria to sustain various mitochondrial processes like substrate and ion-exchange, protein import and mitochondrial fusion. The adaptive program was unable to compensate for the lack of Ca 2+ -stimulated mitochondrial ATP generation during cell stimulation. This highlights the crucial role of mitochondria when the cell faces acute increases in ATP demand.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.bbadis.2014.12.012.
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